We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AMN Healthcare Services, Inc. announced that it has priced its private offering of senior notes due 2024. The offering was first announced on Sep 19, 2016. The company has also increased the size of the offering from $300 million to $325 million. The senior notes will bear an interest rate of 5.125% per annum and will be issued at 100.00% of their face value. The offering is expected to close on Oct 3, 2016.
AMN Healthcare Services intends to use the proceeds from the private offering to repay $138.4 million of the existing term loan indebtedness under its credit facilities. It will also utilize $182.5 million from the proceeds to repay the revolving portion of its credit facilities and pay fees and expenses related to the offering. As of Jun 30, 2016, the company had cash and cash equivalents of $21 million. The company ended the second quarter of 2016 with total debt outstanding of $413 million.
AMN Healthcare Services is one of the largest domestic healthcare staffing companies. The company recruits healthcare professionals from around the globe for both temporary and longer-term assignments in the U.S. It is the leading staffing services’ provider of travel nurses and allied health professionals, and physician permanent placement services. AMN reports its business through three segments – nurse and allied solutions, locum tenens solutions, and other workforce solutions.
Currently, AMN Healthcare carries a Zacks Rank #2 (Buy). Other well-placed stocks in the medical sector include GW Pharmaceuticals plc , NuVasive, Inc. and Baxter International Inc. (BAX - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
GW Pharmaceuticals consistently surpassed expectations in the last four quarters, with an average positive surprise of 41.67%. This represents an impressive year-to-date return of approximately 54.9%, better than the S&P 500’s 5.9% over the same period.
NuVasive also has a steady record in beating earnings expectations in each of the last four quarters, with an average positive surprise of 18.98%. Year to date, the stock has outperformed the S&P 500 with a gain of approximately 23.4%.
Finally, Baxter International also surpassed expectations in each of the last four quarters, with an average positive surprise of 30.55%. This represents an impressive year-to-date return of approximately 24.48%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
AMN Healthcare Services (AHS) Prices Senior Notes Offering
AMN Healthcare Services, Inc. announced that it has priced its private offering of senior notes due 2024. The offering was first announced on Sep 19, 2016. The company has also increased the size of the offering from $300 million to $325 million. The senior notes will bear an interest rate of 5.125% per annum and will be issued at 100.00% of their face value. The offering is expected to close on Oct 3, 2016.
AMN Healthcare Services intends to use the proceeds from the private offering to repay $138.4 million of the existing term loan indebtedness under its credit facilities. It will also utilize $182.5 million from the proceeds to repay the revolving portion of its credit facilities and pay fees and expenses related to the offering. As of Jun 30, 2016, the company had cash and cash equivalents of $21 million. The company ended the second quarter of 2016 with total debt outstanding of $413 million.
AMN Healthcare Services is one of the largest domestic healthcare staffing companies. The company recruits healthcare professionals from around the globe for both temporary and longer-term assignments in the U.S. It is the leading staffing services’ provider of travel nurses and allied health professionals, and physician permanent placement services. AMN reports its business through three segments – nurse and allied solutions, locum tenens solutions, and other workforce solutions.
AMN HLTHCR SVCS Price
AMN HLTHCR SVCS Price | AMN HLTHCR SVCS Quote
Zacks Rank & Key Picks
Currently, AMN Healthcare carries a Zacks Rank #2 (Buy). Other well-placed stocks in the medical sector include GW Pharmaceuticals plc , NuVasive, Inc. and Baxter International Inc. (BAX - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
GW Pharmaceuticals consistently surpassed expectations in the last four quarters, with an average positive surprise of 41.67%. This represents an impressive year-to-date return of approximately 54.9%, better than the S&P 500’s 5.9% over the same period.
NuVasive also has a steady record in beating earnings expectations in each of the last four quarters, with an average positive surprise of 18.98%. Year to date, the stock has outperformed the S&P 500 with a gain of approximately 23.4%.
Finally, Baxter International also surpassed expectations in each of the last four quarters, with an average positive surprise of 30.55%. This represents an impressive year-to-date return of approximately 24.48%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>